Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in non-small cell lung cancer: A real-world study.

被引：0
|
作者：
Wu, Fang [1 ]
Wu, Sixuan [1 ]
Hu, Chunhong [1 ]
机构：
[1] Cent S Univ, Xiangya Hosp 2, Dept Oncol, Changsha, Hunan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e20640
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20640
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in non-small cell lung cancer: A real-world study
    Wu, F.
    Wu, S. X.
    Hu, H. C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in EGFR-mutated non-small cell lung cancer: A real-world study
    Hu, Chunhong
    Wu, Sixuan
    Deng, Renfang
    Wu, Yuanqiang
    Pan, Yue
    Shu, Long
    Wu, Fang
    CANCER MEDICINE, 2023, 12 (01): : 266 - 273
  • [3] Real-World Study of EGFR-TKIs Combined With Radiotherapy in Patients With Brain Metastases From Non-small Cell Lung Cancer
    Liu, Yi
    Zhu, Yaning
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S11 - S11
  • [4] Comparison of first and third generation EGFR-TKIs for the treatment of advanced non-small cell lung cancer: A real-world study
    Shah, Maitri
    Shah, Kashvi
    Dave, Hetvi
    Khadela, Avinash
    Desai, Chirag
    Shah, Sanket
    Shah, Gaurang
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025,
  • [5] The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study
    Yu, Xiaoqing
    Si, Jinfei
    Wei, Jingwen
    Wang, Yanling
    Sun, Yan
    Jin, Jianan
    Zhang, Xiaoyan
    Ma, Tonghui
    Song, Zhengbo
    CANCER MEDICINE, 2023, 12 (05): : 5630 - 5638
  • [6] Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer
    Yu, Yinan
    Zhao, Jianguo
    Xu, Jiaona
    Bai, Rui
    Gu, Zewei
    Chen, Xialin
    Wang, Jianfang
    Jin, Xueying
    Gu, Gaoyang
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (12) : 1889 - 1916
  • [7] Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer
    Yinan Yu
    Jianguo Zhao
    Jiaona Xu
    Rui Bai
    Zewei Gu
    Xialin Chen
    Jianfang Wang
    Xueying Jin
    Gaoyang Gu
    Current Treatment Options in Oncology, 2023, 24 : 1935 - 1947
  • [8] Real-world impact of brain metastases on healthcare utilization and costs in patients with non-small cell lung cancer treated with EGFR-TKIs in the US
    Kong, Amanda M.
    Pavilack, Melissa
    Huo, Hairong
    Shenolikar, Rahul
    Moynihan, Meghan
    Marchlewicz, Elizabeth H.
    Chebili-Larson, Christina
    Min, Stella
    Subramaniam, Deepa S.
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 328 - 338
  • [9] Clinical efficacy and safety of apatinib combined with EGFR-TKIs in advanced non-small cell lung cancer with EGFR-TKIs resistance
    Tian, Ruifen
    Guo, Yi
    Zhang, Xia
    Zhang, Xing
    Guo, Wei
    Zhu, Haibo
    Xu, Junjun
    Shen, Fangfang
    Song, Xia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Safety of EGFR-TKIs for EGFR mutation-positive non-small cell lung cancer
    Zhou, Jia-Ying
    Liu, Si-Yang
    Wu, Yi-Long
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (05) : 589 - 599
12345